BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20402949)

  • 1. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
    Moehrle M; Breuninger H; Schippert W; Häfner HM
    Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
    [No Abstract]   [Full Text] [Related]  

  • 2. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
    Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
    Butler DF; Parekh PK; Lenis A
    Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
    Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
    Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
    Ezughah FI; Affleck AG; Evans A; Ibbotson SH; Fleming CJ
    J Dermatolog Treat; 2008; 19(3):156-8. PubMed ID: 18569271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
    Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
    Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
    [No Abstract]   [Full Text] [Related]  

  • 8. The utility of the 'book biopsy' in Mohs micrographic surgery.
    Hussain W; Hafiji J; Salmon P
    Br J Dermatol; 2012 Sep; 167(3):701-3. PubMed ID: 22463381
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
    Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
    Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When imiquimod fails.
    Firoz BF; Goldberg LH
    Dermatol Surg; 2010 May; 36(5):717-20. PubMed ID: 20384736
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream.
    Vanaclocha F; Daudén E; Badía X; Guillén C; Conejo-Mir JS; Sainz de Los Terreros M; Hamel L; Llorens MA;
    Br J Dermatol; 2007 Apr; 156(4):769-71. PubMed ID: 17263811
    [No Abstract]   [Full Text] [Related]  

  • 14. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
    Ozolins M; Williams HC; Armstrong SJ; Bath-Hextall FJ
    Trials; 2010 Apr; 11():42. PubMed ID: 20409337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular and cystic regression of locally advanced basal cell carcinoma following short-term neoadjuvant vismodegib therapy.
    Mohr M; Schumacher N; Zillikens D; Terheyden P
    J Dtsch Dermatol Ges; 2017 Oct; 15(10):1031-1033. PubMed ID: 28898543
    [No Abstract]   [Full Text] [Related]  

  • 16. Micrographic surgery of malignant skin tumors: a comparison of the frozen technique with paraffin sectioning.
    Breuninger H
    Facial Plast Surg; 1997 Apr; 13(2):79-82. PubMed ID: 9243982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evidence-based medicine: Analysis of the randomized trial "imiquimod vs. surgery for basal cell carcinoma"].
    Guillot B
    Ann Dermatol Venereol; 2015 May; 142(5):369-70. PubMed ID: 25749512
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
    Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
    Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alternative to surgery in basal cell carcinoma in the elderly population: imiquimod 5% cream].
    Arias Santiago SA; Ruiz Villaverde R; Burkhardt Pérez P; Naranjo Sintes R
    Rev Esp Geriatr Gerontol; 2009; 44(2):94-7. PubMed ID: 19285364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.